ES2058780T3 - Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular. - Google Patents

Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular.

Info

Publication number
ES2058780T3
ES2058780T3 ES90301082T ES90301082T ES2058780T3 ES 2058780 T3 ES2058780 T3 ES 2058780T3 ES 90301082 T ES90301082 T ES 90301082T ES 90301082 T ES90301082 T ES 90301082T ES 2058780 T3 ES2058780 T3 ES 2058780T3
Authority
ES
Spain
Prior art keywords
cinamamide
manufacture
relax
derivatives
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301082T
Other languages
English (en)
Inventor
Hironaka Aihara
Michio Kurachi
Kazuyuki Tomisawa
Kazuya Kameo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2058780T3 publication Critical patent/ES2058780T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN DERIVADO DE LA CINAMAMIDA DE FORMULA $ (EN DONDE X ES UN HALOGENO) ES UTIL COM ORELAJANTE MUSCULAR Y ES EMPLEADO PARA FABRICAR COMPUESTOS FARMACEUTICOS PARA REFLEJAR EL TONO MUSCULAR.
ES90301082T 1989-02-02 1990-02-01 Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular. Expired - Lifetime ES2058780T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2415989 1989-02-02

Publications (1)

Publication Number Publication Date
ES2058780T3 true ES2058780T3 (es) 1994-11-01

Family

ID=12130557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301082T Expired - Lifetime ES2058780T3 (es) 1989-02-02 1990-02-01 Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular.

Country Status (8)

Country Link
US (1) US5116877A (es)
EP (1) EP0381508B1 (es)
JP (1) JPH0714871B2 (es)
AT (1) ATE91077T1 (es)
CA (1) CA2009009A1 (es)
DE (1) DE69002062T2 (es)
DK (1) DK0381508T3 (es)
ES (1) ES2058780T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9101244D0 (en) * 1991-01-19 1991-02-27 Wellcome Found Amide derivatives and their therapeutic use
FR2739216B1 (fr) * 1995-09-22 1997-10-24 Commissariat Energie Atomique Procede de traitement de combustibles et/ou de cibles nucleaires a base d'aluminium metallique par des solutions d'hydroxyde de tetramethylammonium
US7329767B2 (en) * 2003-10-03 2008-02-12 International Flavors & Fragrances Inc. Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
PL209602B1 (pl) 2005-10-20 2011-09-30 Inst Chemii Bioorg Pan Sposób otrzymywania amidu kwasu 3-(4-hydroksyfenylo)propanowego

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131727A (en) * 1966-05-10 1968-10-23 Smith Kline French Lab Antidepressant n,n-dimethylcinnamamide compositions
FR2040181A1 (es) * 1969-04-02 1971-01-22 Lipha
GB1568401A (en) * 1976-02-03 1980-05-29 Wellcome Found Biologically active amides
US4309444A (en) * 1976-02-03 1982-01-05 Burroughs Wellcome Co. Biologically active amides
US4190647A (en) * 1979-01-26 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptides and methods

Also Published As

Publication number Publication date
EP0381508B1 (en) 1993-06-30
JPH02288823A (ja) 1990-11-28
DE69002062D1 (de) 1993-08-05
JPH0714871B2 (ja) 1995-02-22
ATE91077T1 (de) 1993-07-15
CA2009009A1 (en) 1990-08-02
EP0381508A2 (en) 1990-08-08
US5116877A (en) 1992-05-26
DK0381508T3 (da) 1993-08-02
DE69002062T2 (de) 1993-10-21
EP0381508A3 (en) 1990-09-19

Similar Documents

Publication Publication Date Title
DK1169298T3 (da) Farmaceutiske forbindelser
FI20040479A (fi) 3-aminopiperidiinijohdannaisia ja menetelmiä niiden valmistamiseksi
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
ES2057004T3 (es) N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel.
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
ES2058780T3 (es) Uso de derivados de cinamamida en la fabricacion de una composicion farmaceutica para relajar el tono muscular.
TW372238B (en) N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics
YU39392A (sh) Sastav smeše aktivnih jedinjenja inhibitora karbonske anhidraze i beta-adrenergičnog antagonista
ITMI911470A0 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
ATA20492A (de) Protein c-hältige pharmazeutische präparation
ES553207A0 (es) Un procedimiento para la preparacion de una octahidroindolizina
NO180485C (no) NMDA-antagonister
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
KR910009265A (ko) 마취제의 제조에 있어서의 이미다조피리딘의 사용
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
ES2055925T3 (es) Derivados de la 9-fluor-prostaglandina, procedimiento para su obtencion y su uso farmaceutico.
KR920007626A (ko) 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
IT8909484A0 (it) Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381508

Country of ref document: ES